COGENT BIOSCIENCES INC (COGT)

US19240Q2012 - Common Stock

7.45  -0.74 (-9.04%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to COGT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 16.69. This target is 124.04% above the current price.
COGT was analyzed by 17 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about COGT.
In the previous month the buy percentage consensus was at a similar level.
COGT was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 7.4510.1016.3216.6924.15 - 35.57% 119.06% 124.04% 224.16%
Up and Down Grades
Date Firm Action Rating
2024-12-11 Needham Downgrade Buy -> Hold
2024-12-11 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-10 Needham Reiterate Buy -> Buy
2024-12-09 Needham Reiterate Buy -> Buy
2024-11-14 JP Morgan Maintains Overweight -> Overweight
2024-11-13 Needham Maintains Buy -> Buy
2024-11-04 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-24 Needham Reiterate Buy -> Buy
2024-09-24 Citigroup Maintains Buy -> Buy
2024-09-05 Baird Maintains Neutral -> Neutral
2024-09-03 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-07 Needham Reiterate Buy -> Buy
2024-08-07 JP Morgan Maintains Overweight -> Overweight
2024-06-27 Needham Reiterate Buy -> Buy
2024-06-17 Needham Reiterate Buy -> Buy
2024-06-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-24 Wedbush Reiterate Neutral -> Neutral
2024-05-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-08 Needham Reiterate Buy -> Buy
2024-02-27 JP Morgan Maintains Overweight -> Overweight
2024-02-26 Needham Reiterate Buy -> Buy
2024-02-26 Baird Downgrade Outperform -> Neutral
2024-02-26 Citigroup Maintains Buy -> Buy
2024-02-23 Wedbush Maintains Neutral -> Neutral
2024-02-12 Needham Reiterate Buy -> Buy
2024-02-08 Citigroup Initiate Buy
2023-12-15 HC Wainwright & Co. Maintains Buy -> Buy
2023-12-11 Wedbush Downgrade Outperform -> Neutral
2023-12-08 JP Morgan Initiate Overweight
2023-12-05 Needham Reiterate Buy -> Buy